Eli Lilly’s Diversification Offers Stronger Investment Case
Beyond its weight-loss drug success, Eli Lilly's robust pipeline across oncology, immunology, and neuroscience presents a compelling investment thesis.

Beyond its weight-loss drug success, Eli Lilly's robust pipeline across oncology, immunology, and neuroscience presents a compelling investment thesis.

Analysts predict Amazon's diversified model, while innovative, may limit its growth potential compared to more focused peers within the 'Magnificent Seven' over...

The S&P 500 hits all-time highs while consumer sentiment plummets. This apparent contradiction is explained by equity ownership disparity and market-cap weighting.

Advanced Micro Devices (AMD) shares climbed over 9% today, driven by a bullish 'overweight' rating from Barclays analyst Blayne Curtis, who forecasts...

US stocks closed higher Friday, with the S&P 500 and Nasdaq 100 reaching new all-time highs driven by strong tech performance and...

Bank of England Deputy Governor Sarah Breeden signals concern over elevated asset prices, warning of an inevitable market correction due to unacknowledged...

Tesla's Cybercab has entered pilot production, fueling optimism for its autonomous ride-sharing future. However, questions remain about its near-term financial impact and...

The dollar index reached a 1.5-week high, buoyed by Middle East tensions and rising crude oil prices, while stock markets experienced a...

Nucor Corp. (NUE) is positioned at #35 among 50 top global metals and mining stocks in a recent analyst recommendation study by...